The Manufacturers Life Insurance Company acquired a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) during the 3rd quarter, HoldingsChannel reports. The fund acquired 18,563 shares of the company’s stock, valued at approximately $52,000.
Several other institutional investors have also modified their holdings of the stock. KKM Financial LLC lifted its stake in ASP Isotopes by 66.2% in the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after buying an additional 9,000 shares in the last quarter. Renaissance Technologies LLC increased its stake in ASP Isotopes by 5.7% during the 2nd quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock worth $526,000 after buying an additional 9,200 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of ASP Isotopes by 16.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock valued at $334,000 after acquiring an additional 17,159 shares during the last quarter. Fielder Capital Group LLC purchased a new position in shares of ASP Isotopes in the second quarter valued at approximately $55,000. Finally, Rhumbline Advisers acquired a new stake in shares of ASP Isotopes in the second quarter worth approximately $116,000. Institutional investors and hedge funds own 16.80% of the company’s stock.
Analyst Ratings Changes
Several research analysts recently commented on the company. Canaccord Genuity Group started coverage on ASP Isotopes in a report on Friday, October 4th. They issued a “buy” rating and a $4.50 price objective on the stock. Canaccord Genuity Group reissued a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a research note on Friday, October 18th.
ASP Isotopes Stock Performance
Shares of ASP Isotopes stock opened at $5.45 on Wednesday. The business’s 50 day moving average price is $5.68 and its 200 day moving average price is $3.90. The company has a market cap of $389.08 million, a price-to-earnings ratio of -8.89 and a beta of 3.27. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. ASP Isotopes Inc. has a one year low of $1.65 and a one year high of $9.33.
ASP Isotopes Profile
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Further Reading
- Five stocks we like better than ASP Isotopes
- Breakout Stocks: What They Are and How to Identify Them
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Investing in Construction Stocks
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- What is the Nasdaq? Complete Overview with History
- Salesforce’s Clear Path to $400 and Beyond
Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI – Free Report).
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.